Geo Capital Gestora de Recursos Ltd decreased its holdings in Novo Nordisk A/S by 8.2% in the first quarter, selling 5,826 shares. The fund retains 65,515 shares, demonstrating continued confidence in the pharmaceutical company despite the latest change.

The Trump administration has initiated investigations into the importation of pharmaceuticals and semiconductors, aiming to impose tariffs on these sectors due to national security concerns. Notices released in the Federal Register outline a 21-day public comment period, signaling potential changes in trade policy affecting critical industries.